https://www.selleckchem.com/pr....oducts/dorsomorphin-
013) were independent risk factors for PFS. Patients with adrenal metastasis tended to be at the highest risk of not benefiting from bevacizumab addition (HR [95% CI] 2.244 [0.6495-7.753]). The safety profile was acceptable, and grade ≥3 toxicity occurred similarly. This study showed that pemetrexed-platinum plus bevacizumab was effective compared to chemotherapy alone in Chinese patients with advanced NSCLC.Background Osteoarthritis (OA) is imposing substantial burdens on individuals and society with the aging population. Cor
Like
Comment
Share
